stockrowQuest Diagnostics Incorporated
DGX Healthcare Diagnostics & Research
Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024.
- Revenue
- +9.98%
- EPS
- +29.4%
- Free cash flow
- +6.21%
- Total debt
- −2.20%
Quarter to September 2026, against a year earlier
Follow DGX
Alert me
Quest Diagnostics Incorporated (DGX) Return on equity
Quest Diagnostics Incorporated's return on equity over the twelve months to 30 September 2026 was 14.8%, up 0.7 percentage points from fiscal 2025 (14.1%). Over the past ten years it has ranged from 13.2% (fiscal 2024) to 29.9% (fiscal 2021); the current reading is higher than 36% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 14.1% | 0.93 |
| FY2024 | 13.2% | (0.68) |
| FY2023 | 13.9% | (1.33) |
| FY2022 | 15.2% | (14.73) |
| FY2021 | 29.9% | 7.10 |
| FY2020 | 22.8% | 7.14 |
| FY2019 | 15.7% | 1.27 |
| FY2018 | 14.4% | (1.66) |
| FY2017 | 16.1% | 2.36 |
| FY2016 | 13.7% | (1.91) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| GH Guardant Health, Inc. compare | 153.9% |
| MEDP Medpace Holdings, Inc. compare | 117.9% |
| ILMN Illumina, Inc. compare | 32.4% |
| IQV IQVIA Holdings Inc. compare | 21.3% |
| DGX Quest Diagnostics Incorporated | 14.8% |
| LH Labcorp Holdings Inc. compare | 11.5% |
| WAT Waters Corporation compare | 0.00% |
| RVTY Revvity Inc. compare | 0.00% |
| MTD Mettler-Toledo International, Inc. compare | −736.4% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on DGX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement